Takhoma Medical is developing the CPR Companion — the first device to deliver real-time physiological feedback during CPR, confirming whether compressions are generating life-saving oxygenated blood to the vital organs of the body.
Guideline-compliant CPR can still fail to produce meaningful blood flow to the brain. Anatomical variability, improper hand placement, and collapse of the left ventricular outflow tract can all render compressions ineffective — even when performed "correctly."
Today's rescuers — lay bystanders are not equipped to acurately determine perfusion and even EMS professionals are compromised until ALS equipment arrives such as Ultrasound/Cardiac-Monitor Defibrillators/NIBP/SpO2 devices. Resuscitation thought leaders formally identified this as a major unmet clinical need in 2023. Takhoma Medical is the answer.
"Current CPR tools measure how compressions are delivered — not whether they are physiologically effective for the individual patient." — Takhoma Medical Clinical Brief, 2026
The CPR Companion — showing the three-light perfusion status display, built-in audio instruction speaker, and the two patient-contact sensor pads: Sternum and Matrix.
A compact, single-use device that provides real-time physiological feedback during CPR — confirming blood perfusion and coaching rescuers to optimize hand placement for each individual patient. Designed for lay rescuers, EMS, and in-hospital teams. $100 target price. Over two-year battery life.
Monitors Multiple perfusion indicators continuously, telling rescuers whether blood is actually reaching the vital organs of the body — not just how they're compressing.
Guides rescuers to the sternum position that produces the best perfusion for that specific patient's anatomy, in real time.
Designed for use under extreme stress — minimal training required. A universal visual language that works for untrained bystanders and critical care teams alike.
Independent Pressure,Accelerometer, and force sensors applied to optimize compression depth, speed of compression and release, and rate.
One-time-use form factor eliminates concerns over sterilization/cross-contamination and supports rapid deployment across pre-hospital and hospital settings.
Engineered for future integration into existing AEDs and cardiac monitor-defibrillators, Vital Sign Monitors, Central Stations enabling adoption through established clinical channels.
The CPR Companion is designed to work wherever cardiac arrest happens — from a community center floor to a hospital ICU. Its simple interface requires no special training, while its physiology-driven feedback serves the most advanced resuscitation teams equally well.
The three-light interface and audio speaker guides untrained rescuers to effective compressions from the first seconds of a cardiac arrest — when every moment matters most.
Pre-hospital emergency teams gain real-time perfusion data to adapt technique on the scene, improving outcomes before hospital arrival.
Emergency departments and advanced life support teams can optimize in-hospital CPR with the same patient-specific physiological feedback.
Over 25 million people receive CPR training annually worldwide. The CPR Companion can be integrated into training to teach physiology-first technique from the start.
Takhoma Medical is pursuing a rigorous, phased development path designed to generate the clinical evidence necessary to earn FDA 510(k) clearance and demonstrate the CPR Companion's life-saving effectiveness in real-world emergency settings.
Design and production of 10 refined second-generation devices. Engineering validation, bench testing, and hardware refinement to prepare for human subject evaluation.
FDA Nonsignificant Risk authorization and IDE approval, followed by clinical evaluation with Kootenai County emergency medical personnel. Initial 10 person study collecting real-world data on cardiac arrest patients.
A 50-patient human subject study using fully operational CPR Companion units deployed by trained EMS personnel. This study is designed to demonstrate real-world effectiveness and generate the clinical data required for FDA 510(k) clearance.
Submission and clearance under the FDA Class II 510(k) pathway, followed by initial deployment with emergency medical services in the Seattle–Spokane–Coeur d'Alene region.
Takhoma's team has collectively contributed to the development and clinical deployment of more than 14 life-saving medical products — with deep expertise across medical devices, clinical research, EMS, regulatory affairs, and FDA-regulated development pathways.
49 years in medical device development and commercialization.
43 years' experience with public and private companies.
40 years of clinical nursing and research leadership.
35 years in embedded systems and medical software engineering.
32 years navigating FDA-regulated clinical and regulatory pathways.
35 years as an EMS professional and certified CPR instructor.
45 years in medical research, resuscitation science, and device validation.
Life-saving medical products developed and brought to patients by this team. Combined experience spans 279+ years across medical devices, clinical care, EMS, software, and regulatory affairs.
We welcome inquiries from emergency medical professionals, clinical researchers, EMS organizations, and others who share our commitment to improving cardiac arrest survival. Reach out to learn more about the CPR Companion or our clinical development program.
Contact Us